Heart failure & cardiomyopathies
Early Occurrence of Heart Failure Hospitalization or Ventricular Arrhythmia Re-Define the Long-Term Prognosis After Cardiac Resynchronization Therapy (CRT)
Authors' conclusion
Long-term survival can be predicted based on the change in LVEF and on the occurrence of an HHF/VA event within 1-year after CRT-D implantation. Stabilized patients have significantly better prognosis as compared with the worsened group. Patients with strikingly poor prognosis can be identified using this assessment method.
Study context
- Population
- Patients implanted with a CRT defibrillator (CRT-D)by echocardiographic response
- Comparison
- Long-term survival free of heart transplantation or LV assist device implantation across LV ejection fraction (LVEF)-response categories with or without an HHF/VA event within 1-year post-implantation
- Respondersn = One hundred nineteen
- Non-progressorsn = 79reference
- Progressorsn = 69reference
- Outcome
- Long-term event-free survival by echocardiographic response
Methodological detailssingle department, 2010–2020
- Single department
- 2010–2020
Main finding
As reported in the abstract
Hazard ratio
0.51
P = 0.002
responders vs non-progressors
Hazard ratio
0.34
P < 0.0001
responders vs progressors
Hazard ratio
0.63
P = 0.03
non-progressors vs progressors
Further findings
Median survival by improved, stabilized and worsened groups — improved vs stabilized
HR 0.53 · P = 0.006
| Outcome | HR | P value |
|---|---|---|
| Long-term prognosis with versus without an HHF/VA event within each groupWith HHF/VA event vs without HHF/VA event | 0.47 | P = 0.03 |
| Long-term prognosis with versus without an HHF/VA event within each groupWith HHF/VA event vs without HHF/VA event · non-progressors | 0.31 | P = 0.0001 |
| Long-term prognosis with versus without an HHF/VA event within each groupWith HHF/VA event vs without HHF/VA event · progressors | 0.38 | P = 0.0004 |
| Survival between subgroups used for recategorizationResponders with no event vs non-progressors with no event · recategorized as improved | 0.69 | P = 0.09 |
| Survival between subgroups used for recategorizationResponders with any event vs progressors with no event · stabilized | 0.98 | P = 0.88 |
| Survival between subgroups used for recategorizationNon-progressors with any event vs progressors with any event · worsened | 0.87 | P = 0.63 |
| Median survival by improved, stabilized and worsened groupsStabilized vs worsened | 0.41 | P < 0.0001 |
| Median survival by improved, stabilized and worsened groupsImproved vs worsened | 0.21 | P < 0.0001 |
- Long-term prognosis with versus without an HHF/VA event within each group: responders; direction as printed ("superior with versus without")
Original publication
Composed by AI from the published abstract and checked against it. How Briefs are made →